FactSet Research Systems
- Market cap
- 9.70B
- P/E (TTM)i
- 18.72
- P/Bi
- 4.85
- EPSi
- 14.57
- Div yieldi
- 1.66%
- 52W posi
- 65%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 115.31% -0.03pp
- Institutions
- 913 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 40 buys · 10 sells
| Name | Role | Stake |
|---|---|---|
| Sanoke Viswanathan | Chief Executive Officer | 0.14% |
| Christopher Ellis | Head of Strategic Initiatives | 0.07% |
| Frederick Snow | Chief Executive Officer | 0.05% |
| Robin Abrams | Independent Chairperson | 0.04% |
| Helen Shan | Chief Revenue Officer | 0.02% |
| Goran Skoko | Executive VP, MD of EMEA & Asia Pacific and Head of Research & Advisory Solutions | 0.01% |
| James McGonigle | Lead Independent Director | 0.01% |
| Christopher McLoughlin | Chief Legal Officer | 0.01% |
| Kristina Karnovsky | Chief Product Officer | 0.01% |
| Robert Robie | Executive VP and Head of Analytics & Trading Solutions | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-22 | Gregory Moskoff | MD, Controller & Chief Accounting Officer | Other Derivative Acquisition | +97 | -- |
| 2026-09-21 | Sanoke Viswanathan | Chief Executive Officer | Sale to Issuer | -8,065 | $276.42 |
| 2026-04-30 | Joshua Warren | Chief Financial Officer | Other Acquisition | +2,272 | -- |
| 2026-04-30 | Joshua Warren | Chief Financial Officer | Other Derivative Acquisition | +8,567 | $227.58 |
| 2026-02-02 | Gregory Moskoff | MD, Controller & Chief Accounting Officer | Sale to Issuer | -9 | $222.62–474.41 |
| 2026-01-14 | Robin Abrams | Independent Chairperson | Other Acquisition | +604 | -- |
| 2026-01-14 | Robin Abrams | Independent Chairperson | Other Derivative Acquisition | +1,477 | $289.68 |
| 2026-01-14 | Laurie Hylton | Director | Other Acquisition | +439 | -- |
| 2026-01-14 | Laurie Hylton | Director | Other Derivative Acquisition | +1,074 | $289.68 |
| 2026-01-14 | Laurie Siegel | Independent Director | Other Acquisition | +626 | -- |
| 2026-01-14 | Laurie Siegel | Independent Director | Other Derivative Acquisition | +1,531 | $289.68 |
| 2026-01-14 | Malcolm Frank | Independent Director | Other Acquisition | +713 | -- |
| 2026-01-14 | Malcolm Frank | Independent Director | Other Derivative Acquisition | +1,743 | $289.68 |
| 2026-01-14 | Lee Shavel | Independent Director | Other Acquisition | +571 | -- |
| 2026-01-14 | Lee Shavel | Independent Director | Other Derivative Acquisition | +1,396 | $289.68 |
| 2026-01-14 | Barak Eilam | Director | Other Acquisition | +439 | -- |
| 2026-01-14 | Barak Eilam | Director | Other Derivative Acquisition | +1,074 | $289.68 |
| 2026-01-14 | Maria Tejada | Independent Director | Other Acquisition | +439 | -- |
| 2026-01-14 | Maria Tejada | Independent Director | Other Derivative Acquisition | +1,074 | $289.68 |
| 2026-01-14 | Shlomo Wiesel | Director | Other Acquisition | +571 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 05:46:37 · For reference only, not investment advice and not tailored to your situation.